Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

GLP-1 drugs, widely used for treating metabolic disorders, often face issues with long term tolerability, leading to side effects such as sarcopenia and bone density loss. These complications ...

Quanterix Corp. agreed to acquire life sciences peer Akoya Biosciences Inc. in an all-stock deal, combining two companies ...

In October 2023, a group that included Elliott Investment Management, Patient Square Capital and Veritas Capital acquired ...

Trial confirms elinzanetant's efficacy and safety in addressing vasomotor symptoms caused by adjuvant endocrine therapy in ...

Press Release Prudentia Sciences, an AI-powered technology platform for life sciences announced today its public launch, supported by $7 million in funding. The funding round was led by GV, with ...

This Genomic Biomarkers market report covers market characteristics, size and growth, segmentation, regional and country ...

The Q4 data highlights sustained growth in key specialty sectors, marked by notable increases in SP drug approvals and ...

About a year ago, Tenvie President and Chief Scientific Officer Tony Estrada approached Denali CEO Ryan Watts and others in ...

Designing an RNA-Seq experiment is a multi-faceted process that requires careful planning and execution. From selecting the right assay to optimizing library preparation, every decision impacts the ...